We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

132 hedge funds and large institutions have $803M invested in Alder Biopharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 62 increasing their positions, 24 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 24

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

35% more capital invested

Capital invested by funds: $595M → $803M (+$208M)

22% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 23

3% more funds holding

Funds holding: 128 → 132 (+4)

22% less call options, than puts

Call options by funds: $1.86M | Put options by funds: $2.39M

Holders
132
Holders Change
+4
Holders Change %
+3.13%
% of All Funds
3.29%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
28
Increased
62
Reduced
24
Closed
23
Calls
$1.86M
Puts
$2.39M
Net Calls
-$532K
Net Calls Change
+$4.38M

Top Buyers

1
RG
Redmile Group
California
+$44.3M
2
State Street
State Street
Massachusetts
+$18.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.6M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.7M
5
PA
Pinnacle Associates
New York
+$12.6M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$22.7M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$14.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.8M
4
PHS
PFM Health Sciences
California
-$9.55M
5
AAMU
Amundi Asset Management US
Massachusetts
-$5.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
CHP
126
Cable Hill Partners
Oregon
$2K -$52 -5 -3%
US Bancorp
127
US Bancorp
Minnesota
$2K +$1.44K +138 New
MAM
128
Meeder Asset Management
Ohio
$1K -$772 -74 -50%
GRP
129
Global Retirement Partners
California
$1K – – –
SEI Investments
130
SEI Investments
Pennsylvania
$1K +$907 +87 New
PHS
131
PFM Health Sciences
California
– -$9.55M -834,191 Closed
AAMU
132
Amundi Asset Management US
Massachusetts
– -$5.36M -467,813 Closed
GTC
133
Ghost Tree Capital
New York
– -$2.86M -250,000 Closed
BBA
134
Baker Bros. Advisors
New York
– -$2.49M -217,328 Closed
Fiera Capital (Canada)
135
Fiera Capital (Canada)
Quebec, Canada
– -$1.67M -145,658 Closed
LSC
136
Lesa Sroufe & Co
Washington
– -$1.48M -129,267 Closed
SSA
137
Schonfeld Strategic Advisors
New York
– -$617K -53,865 Closed
Russell Investments Group
138
Russell Investments Group
United Kingdom
– -$486K -42,416 Closed
FRM
139
Fox Run Management
Connecticut
– -$402K -35,100 Closed
TRSOTSOK
140
Teachers Retirement System of the State of Kentucky
Kentucky
– -$350K -30,610 Closed
Millennium Management
141
Millennium Management
New York
– -$329K -28,728 Closed
SG Americas Securities
142
SG Americas Securities
New York
– -$178K -15,580 Closed
PIM
143
Partner Investment Management
California
– -$175K -15,296 Closed
DSI
144
Daiwa SB Investments
Japan
– -$117K -10,255 Closed
PHK
145
Point72 Hong Kong
Hong Kong
– -$77K -6,766 Closed
Creative Planning
146
Creative Planning
Kansas
– -$70K -6,144 Closed
QT
147
Quantbot Technologies
New York
– -$53K -4,696 Closed
OAM
148
Oppenheimer Asset Management
New York
– -$49K -4,260 Closed
DADC
149
D.A. Davidson & Co
Montana
– -$38K -3,397 Closed
Parallax Volatility Advisers
150
Parallax Volatility Advisers
California
– -$23K -2,043 Closed
3 4 5
6
7

ALDR Hedge Fund Activity: Q3 2017 in Review

132 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q3 2017, worth a combined $803M — up 35% from $595M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ALDR positions and 23 closed out — a net gain of 5 holders — while 62 added to existing stakes and 24 trimmed.

The largest buyer was Redmile Group, adding an estimated $44.3M. The largest seller was Janus Henderson Group, cutting an estimated $22.7M.

  • 132 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q3 2017, up from 128 in Q2 2017.
  • Funds reported $803M of Alder Biopharmaceuticals stock for Q3 2017, up 35% quarter-over-quarter.
  • 28 funds opened new Alder Biopharmaceuticals positions in Q3 2017 and 23 closed out, a net change of +5 holders.
  • The largest Alder Biopharmaceuticals buyer in Q3 2017 was Redmile Group, an estimated $44.3M added.
  • The largest Alder Biopharmaceuticals seller in Q3 2017 was Janus Henderson Group, an estimated $22.7M sold.

Based on aggregated 13F filings for Q3 2017.